Through specialist collaborators, the EuroMediterranean Institute for Quality and Safety in Health Services (EIQSH) provides research and analytical support to investment funds and organisations evaluating biotechnology companies, with a particular focus on US-listed microcap companies.

The service combines monitoring of clinical and regulatory developments with analysis of capital structure, financing needs, shareholder dilution and market liquidity.

Tailored research reports and valuation scenarios highlight investment prospects, material uncertainties and the factors shaping shareholder value.